Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Jazz Pharmaceuticals
JAZZ
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$110.76
-0.53
-0.48%
At Close: -
$110.76
0
0.00%
After Hours: Sep 20, 4:04 PM EDT
15 minutes delayed
Get Report
Comment
Jazz Pharmaceuticals (JAZZ) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock
Jazz Pharmaceuticals Stock (NASDAQ: JAZZ)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, September 19, 2024
FDA-Approved Cannabis-Based Drug Shows Promising Results As A Treatment For War Veterans: Study Finds Improvement In Cognitive, Mood, Pain-Related Symptoms
Rolando García
Monday, September 16, 2024
Jazz Pharmaceuticals Announced Updated Data, ...
Benzinga Newsdesk
Tuesday, September 10, 2024
Needham Reiterates Buy on Jazz Pharmaceutical...
Benzinga Newsdesk
Monday, September 09, 2024
A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk
Jazz Pharmaceuticals Highlights Zanidatamab a...
Benzinga Newsdesk
Friday, September 06, 2024
FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up
Zacks
Wednesday, September 04, 2024
Jazz Pharmaceuticals Launches $850M Senior No...
Benzinga Newsdesk
Tuesday, September 03, 2024
Jazz Intends To Offer $850M Of Exchangeable S...
Benzinga Newsdesk
Wednesday, August 28, 2024
Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices
Vandana Singh
'From Five Minutes Of Agony, It's Now Just Seconds,' Says Brazilian Mother Celebrating Free Access To Her Child's Life-Saving CBD Medicine
Nina Zdinjak
Friday, August 23, 2024
The Only FDA-Approved CBD Treatment For Severe Epilepsy Completes Key Phase 3 Trial In Japan Despite Missed Primary Goal
Nina Zdinjak
Thursday, August 22, 2024
Jazz Pharmaceuticals Provides Update On Canna...
Benzinga Newsdesk
Monday, August 19, 2024
A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals
Benzinga Insights
JP Morgan Maintains Overweight on Jazz Pharma...
Benzinga Newsdesk
Thursday, August 15, 2024
Axsome Banks on Auvelity & Sunosi to Fuel Growth
Zacks
Thursday, August 01, 2024
Decoding 11 Analyst Evaluations For Jazz Pharmaceuticals
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Jazz Ph...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Jazz Phar...
Benzinga Newsdesk
Wells Fargo Maintains Equal-Weight on Jazz Ph...
Benzinga Newsdesk
Needham Maintains Buy on Jazz Pharmaceuticals...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Jazz Ph...
Benzinga Newsdesk
Baird Maintains Outperform on Jazz Pharmaceut...
Benzinga Newsdesk
Wednesday, July 31, 2024
Jazz Pharmaceuticals Sees FY24 Adj EPS $19.20...
Benzinga Newsdesk
Jazz Pharmaceuticals Q2 2024 Adj. EPS $5.30 B...
Benzinga Newsdesk
Monday, July 15, 2024
How Is The Market Feeling About Jazz Pharmaceuticals?
Benzinga Insights
Friday, July 12, 2024
Morgan Stanley Maintains Equal-Weight on Jazz...
Benzinga Newsdesk
Thursday, July 11, 2024
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
Nicolás Jose Rodriguez
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country
Jelena Martinovic
Tuesday, July 02, 2024
Assessing Jazz Pharmaceuticals: Insights From 7 Financial Analysts
Benzinga Insights
UBS Maintains Neutral on Jazz Pharmaceuticals...
Benzinga Newsdesk
Thursday, June 20, 2024
Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday?
Vandana Singh
Needham Maintains Buy on Jazz Pharmaceuticals...
Benzinga Newsdesk
Jazz Pharmaceuticals' Suvecaltamide (JZP385) ...
Benzinga Newsdesk
Wednesday, June 05, 2024
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Avi Kapoor
Decoding 12 Analyst Evaluations For Jazz Pharmaceuticals
Benzinga Insights
Goldman Sachs Initiates Coverage On Jazz Phar...
Benzinga Newsdesk
Monday, June 03, 2024
Reported Saturday, Jazz Pharmaceuticals Showc...
Benzinga Newsdesk
Wednesday, May 29, 2024
Jazz Pharma's Zanidatamab Granted FDA Priorit...
Benzinga Newsdesk
Wednesday, May 22, 2024
Jazz Pharmaceuticals And Life Science Cares C...
Benzinga Newsdesk
Saturday, May 18, 2024
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Nicolás Jose Rodriguez
Wednesday, May 15, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Tuesday, May 14, 2024
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Nicolás Jose Rodriguez
Wednesday, May 08, 2024
Neena M Patil Implements A Sell Strategy: Offloads $548K In Jazz Pharmaceuticals Stock
Benzinga Insights
Friday, May 03, 2024
HC Wainwright & Co. Reiterates Buy on Jazz Ph...
Benzinga Newsdesk
Barclays Maintains Overweight on Jazz Pharmac...
Benzinga Newsdesk
Thursday, May 02, 2024
Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews
Benzinga Insights
Needham Reiterates Buy on Jazz Pharmaceutical...
Benzinga Newsdesk
Wednesday, May 01, 2024
Jazz Pharmaceuticals Affirms 2024 Revenue Gui...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch